Cancer medicine
Journal
Overview
publication venue for
-
Burden of Antimicrobial Resistance in Adult Hospitalized Patients With Cancer: A Multicenter Analysis..
13.
2024
-
Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young- and Average-Onset Gastric Cancer..
13.
2024
-
Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis..
13.
2024
-
Multidimensional Healthcare Access Barriers to Prostate-Specific Antigen Testing: A Nation-Wide Panel Study in the United States From 2006 to 2020..
13.
2024
-
Fertility concerns and treatment decision-making among national sample of young women with breast cancer.
2023
-
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies..
12.
2023
-
A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants..
12.
2023
-
Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understanding.
2023
-
Quantifying mortality burden in patients with cancer due to COVID-19 in the US: A national cross-sectional analysis..
12.
2023
-
Pre-diagnosis lipid levels and mortality after obesity-related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort.
2023
-
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival..
12.
2023
-
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis..
12.
2023
-
Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations..
12.
2023
-
Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer..
12.
2022
-
Establishment of a gastric cancer cell line with high microsatellite instability, OCUM-13, derived from Borrmann type-2 primary tumor..
12.
2022
-
Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation.
2022
-
Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes.
2022
-
Novel protein contact points among TP53 and minichromosome maintenance complex proteins 2, 3, and 5.
2022
-
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
2022
-
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment.
2022
-
Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States..
11.
2021
-
Early implementation of a perioperative nutrition support pathway for patients undergoing esophagectomy for esophageal cancer..
11.
2021
-
Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration.
2021
-
Preexisting immune-mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors..
10.
2021
-
Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States.
2021
-
Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study..
10.
2021
-
Characterizing online crowdfunding campaigns for patients with kidney cancer..
10.
2021
-
The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment..
10.
2021
-
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors..
10.
2021
-
A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract..
10.
2020
-
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium..
10.
2020
-
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study..
9.
2020
-
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib..
9.
2020
-
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study..
9.
2020
-
Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience..
9.
2020
-
Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States..
9.
2020
-
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide..
9.
2020
-
Assessment of variation in 30-day mortality following cancer surgeries among older adults across US hospitals..
9.
2020
-
Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl..
8.
2019
-
Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration..
8.
2019
-
A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer..
8.
2019
-
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients..
8.
2019
-
Case-control study of heart rate abnormalities across the breast cancer survivorship continuum..
8.
2018
-
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials..
8.
2018
-
Determinants of mobile technology use and smartphone application interest in cancer patients..
7.
2018
-
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)..
7.
2018
-
Electronic cigarette use patterns and reasons for use among smokers recently diagnosed with cancer.
2018
-
Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study..
7.
2018
-
An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohort..
7.
2018
-
Being present: oncologists' role in promoting advanced cancer patients' illness understanding..
7.
2018
-
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma..
7.
2018
-
Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases..
6.
2017
-
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma..
6.
2016
-
Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study..
5.
2016
-
Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer..
5.
2016
-
An analysis of the relationship between metastases and cachexia in lung cancer patients..
5.
2016
-
Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer..
4.
2015
-
HER2 as a target in invasive urothelial carcinoma..
4.
2015
-
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling..
3.
2014
-
Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial..
3.
2014
-
Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer..
3.
2014
-
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder..
3.
2014
-
Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT)..
2.
2013
-
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer..
2.
2013
-
Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer..
1.
2012
-
Advanced cancer patients' understanding of prognostic information: Applying insights from psychological research.
2019
-
Efficacy of fusion imaging for immediate post-ablation assessment of malignant liver neoplasms: A systematic review.
2023
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)